Center-Authored Papers

Filters: Author is Gurley, Kay E  [Clear All Filters]
2008
Payne SR, Zhang S, Tsuchiya K, Moser R, Gurley KE, Longton G, deBoer J, Kemp CJ.  2008.  p27kip1 deficiency impairs G2/M arrest in response to DNA damage, leading to an increase in genetic instability.. Molecular and cellular biology. 28(1):258-68. Abstract
Bailey LS, Gurley KE, Hoon-Kim K, Kelly-Spratt KS, Kemp CJ.  2008.  Tumor suppression by p53 in the absence of Atm.. Molecular cancer research : MCR. 6(7):1185-92. Abstract
2009
Gurley KE, Moser R, Gu Y, Hasty P, Kemp CJ.  2009.  DNA-PK suppresses a p53-independent apoptotic response to DNA damage.. EMBO reports. 10(1):87-93. Abstract
Glover CE, Gurley KE, Kim K-H, Storer BE, Fero ML, Kemp CJ.  2009.  Endocrine dysfunction in p27Kip1 deficient mice and susceptibility to Wnt-1 driven breast cancer.. Carcinogenesis. 30(6):1058-63. Abstract
2011
Kelly-Spratt KS, Pitteri SJ, Gurley KE, Liggitt D, Chin A, Kennedy J, Wong C-H, Zhang Q, Busald Buson T, Wang H et al..  2011.  Plasma proteome profiles associated with inflammation, angiogenesis, and cancer.. PloS one. 6(5):e19721. Abstract
Schoenherr RM, Kelly-Spratt KS, Lin C, Whiteaker JR, Liu T, Holzman T, Coleman I, Feng L-C, Lorentzen TD, Krasnoselsky AL et al..  2011.  Proteome and transcriptome profiles of a Her2/Neu-driven mouse model of breast cancer.. Proteomics. Clinical applications. 5(3-4):179-88. Abstract
Pitteri SJ, Kelly-Spratt KS, Gurley KE, Kennedy J, Busald Buson T, Chin A, Wang H, Zhang Q, Wong C-H, Chodosh LA et al..  2011.  Tumor Microenvironment-Derived Proteins Dominate the Plasma Proteome Response during Breast Cancer Induction and Progression.. Cancer research. 71(15):5090-100. Abstract
2012
Moser R, Toyoshima M, Robinson K, Gurley KE, Howie HL, Davison J, Morgan M, Kemp CJ, Grandori C.  2012.  MYC-driven tumorigenesis is inhibited by WRN syndrome gene deficiency.. Molecular cancer research : MCR. 10(4):535-45. Abstract
Busch SE, Gurley KE, Moser RD, Kemp CJ.  2012.  ARF suppresses hepatic vascular neoplasia in a carcinogen-exposed murine model.. The Journal of pathology. 227(3):298-305. Abstract
2014
Uparkar U, Gurley KE, Robinson K, Girard E, Pedro K, Park J, Kemp CJ, Grandori C.  2014.  The Role and Efficacy of Retinoic Acid (Ra) and the Flt3 Inhibitor as Combination Therapy for High Risk Neuroblastoma. Pediatric Blood & Cancer. 61:S96-S96. Abstract
Kemp CJ, Moore JM, Moser R, Bernard B, Teater M, Smith LE, Rabaia NA, Gurley KE, Guinney J, Busch SE et al..  2014.  CTCF Haploinsufficiency Destabilizes DNA Methylation and Predisposes to Cancer.. Cell reports. 7(7):1020-9. Abstract
Moser R, Xu C, Kao M, Annis J, Lerma LA, Schaupp CM, Gurley KE, Jang IS, Biktasova A, Yarbrough WG et al..  2014.  Functional kinomics identifies candidate therapeutic targets in head and neck cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. 20(16):4274-88. Abstract
2015
Gurley KE, Moser RD, Kemp CJ.  2015.  Induction of Colon Cancer in Mice with 1,2-Dimethylhydrazine.. Cold Spring Harbor protocols. 2015(9):pdb.prot077453. Abstract
Gurley KE, Moser RD, Kemp CJ.  2015.  Induction of Liver Tumors in Mice with N-Ethyl-N-Nitrosourea or N-Nitrosodiethylamine.. Cold Spring Harbor protocols. 2015(10):pdb.prot077438. Abstract
Gurley KE, Moser RD, Kemp CJ.  2015.  Induction of Lung Tumors in Mice with Urethane.. Cold Spring Harbor protocols. 2015(9):pdb.prot077446. Abstract
Westcott PMK, Halliwill KD, To MD, Rashid M, Rust AG, Keane TM, Delrosario R, Jen K-Y, Gurley KE, Kemp CJ et al..  2015.  The mutational landscapes of genetic and chemical models of Kras-driven lung cancer.. Nature. 517(7535):489-92. Abstract
2017
Gurley KE, Ashley AK, Moser RD, Kemp CJ.  2017.  Synergy between Prkdc and Trp53 regulates stem cell proliferation and GI-ARS after irradiation.. Cell death and differentiation. Abstract
2018
Xu C, Nikolova O, Basom R, Mitchell RM, Shaw R, Moser R, Park H, Gurley KE, Kao M, Green CL et al..  2018.  Functional precision medicine identifies novel druggable targets and therapeutic options in head and neck cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. 24(12):2828-2843. Abstract